Dara S Ross, Yong Hannah Wen, Edi Brogi. Adv Anat Pathol 2013
Times Cited: 8
Times Cited: 8
Times Cited
Times Co-cited
Similarity
Ductal carcinoma in situ of the breast: current concepts and future directions.
Kalliopi P Siziopikou. Arch Pathol Lab Med 2013
Kalliopi P Siziopikou. Arch Pathol Lab Med 2013
50
HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
50
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.
Rulla M Tamimi, Heather J Baer, Jonathan Marotti, Mark Galan, Laurie Galaburda, Yineng Fu, Anne C Deitz, James L Connolly, Stuart J Schnitt, Graham A Colditz,[...]. Breast Cancer Res 2008
Rulla M Tamimi, Heather J Baer, Jonathan Marotti, Mark Galan, Laurie Galaburda, Yineng Fu, Anne C Deitz, James L Connolly, Stuart J Schnitt, Graham A Colditz,[...]. Breast Cancer Res 2008
50
Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
37
Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery.
John R Benson, Gordon C Wishart. Lancet Oncol 2013
John R Benson, Gordon C Wishart. Lancet Oncol 2013
37
Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.
Bradley B Bryan, Stuart J Schnitt, Laura C Collins. Mod Pathol 2006
Bradley B Bryan, Stuart J Schnitt, Laura C Collins. Mod Pathol 2006
37
Prognostic and predictive molecular markers in DCIS: a review.
Sharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, Wedad Hanna. Adv Anat Pathol 2005
Sharon Nofech-Mozes, Jacqueline Spayne, Eileen Rakovitch, Wedad Hanna. Adv Anat Pathol 2005
37
Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
37
Identification of a basal-like subtype of breast ductal carcinoma in situ.
Chad A Livasy, Charles M Perou, Gamze Karaca, David W Cowan, Diane Maia, Susan Jackson, Chiu-Kit Tse, Sarah Nyante, Robert C Millikan. Hum Pathol 2007
Chad A Livasy, Charles M Perou, Gamze Karaca, David W Cowan, Diane Maia, Susan Jackson, Chiu-Kit Tse, Sarah Nyante, Robert C Millikan. Hum Pathol 2007
37
P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.
Joana Paredes, Nair Lopes, Fernanda Milanezi, Fernando C Schmitt. Virchows Arch 2007
Joana Paredes, Nair Lopes, Fernanda Milanezi, Fernando C Schmitt. Virchows Arch 2007
25
Histologic classification of ductal carcinoma in situ.
Shabnam Jaffer, Ira J Bleiweiss. Microsc Res Tech 2002
Shabnam Jaffer, Ira J Bleiweiss. Microsc Res Tech 2002
25
Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.
David J Dabbs, Mamatha Chivukula, Gloria Carter, Rohit Bhargava. Mod Pathol 2006
David J Dabbs, Mamatha Chivukula, Gloria Carter, Rohit Bhargava. Mod Pathol 2006
25
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.
S E Clark, J Warwick, R Carpenter, R L Bowen, S W Duffy, J L Jones. Br J Cancer 2011
S E Clark, J Warwick, R Carpenter, R L Bowen, S W Duffy, J L Jones. Br J Cancer 2011
25
Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.
Susan C Lester, Shikha Bose, Yunn-Yi Chen, James L Connolly, Monica E de Baca, Patrick L Fitzgibbons, Daniel F Hayes, Celina Kleer, Frances P O'Malley, David L Page,[...]. Arch Pathol Lab Med 2009
Susan C Lester, Shikha Bose, Yunn-Yi Chen, James L Connolly, Monica E de Baca, Patrick L Fitzgibbons, Daniel F Hayes, Celina Kleer, Frances P O'Malley, David L Page,[...]. Arch Pathol Lab Med 2009
25
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.
Sara A Lari, Henry M Kuerer. J Cancer 2011
Sara A Lari, Henry M Kuerer. J Cancer 2011
25
Immunohistochemical profile of high-grade ductal carcinoma in situ of the breast.
Amanda Arantes Perez, Rafael Malagoli Rocha, Débora Balabram, Átila da Silva Souza, Helenice Gobbi. Clinics (Sao Paulo) 2013
Amanda Arantes Perez, Rafael Malagoli Rocha, Débora Balabram, Átila da Silva Souza, Helenice Gobbi. Clinics (Sao Paulo) 2013
40
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
25
The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast.
Melvin J Silverstein. Am J Surg 2003
Melvin J Silverstein. Am J Surg 2003
25
Ductal carcinoma in situ of the breast.
Harold J Burstein, Kornelia Polyak, Julia S Wong, Susan C Lester, Carolyn M Kaelin. N Engl J Med 2004
Harold J Burstein, Kornelia Polyak, Julia S Wong, Susan C Lester, Carolyn M Kaelin. N Engl J Med 2004
25
Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast.
E Provenzano, J L Hopper, G G Giles, G Marr, D J Venter, J E Armes. Eur J Cancer 2003
E Provenzano, J L Hopper, G G Giles, G Marr, D J Venter, J E Armes. Eur J Cancer 2003
25
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
25
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
A Goldhirsch, E P Winer, A S Coates, R D Gelber, M Piccart-Gebhart, B Thürlimann, H-J Senn. Ann Oncol 2013
A Goldhirsch, E P Winer, A S Coates, R D Gelber, M Piccart-Gebhart, B Thürlimann, H-J Senn. Ann Oncol 2013
25
Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
25
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
25
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
Kalliopi P Siziopikou, Stewart J Anderson, Melody A Cobleigh, Thomas B Julian, Douglas W Arthur, Ping Zheng, Eleftherios P Mamounas, Eduardo R Pajon, Robert J Behrens, Janice F Eakle,[...]. Breast Cancer Res Treat 2013
Kalliopi P Siziopikou, Stewart J Anderson, Melody A Cobleigh, Thomas B Julian, Douglas W Arthur, Ping Zheng, Eleftherios P Mamounas, Eduardo R Pajon, Robert J Behrens, Janice F Eakle,[...]. Breast Cancer Res Treat 2013
25
Prognostic classification of breast ductal carcinoma-in-situ.
M J Silverstein, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon. Lancet 1995
M J Silverstein, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon. Lancet 1995
25
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study.
Wenjing Zhou, Karin Jirström, Rose-Marie Amini, Marie-Louise Fjällskog, Thomas Sollie, Henrik Lindman, Therese Sørlie, Carl Blomqvist, Fredrik Wärnberg. BMC Cancer 2013
Wenjing Zhou, Karin Jirström, Rose-Marie Amini, Marie-Louise Fjällskog, Thomas Sollie, Henrik Lindman, Therese Sørlie, Carl Blomqvist, Fredrik Wärnberg. BMC Cancer 2013
25
Classification of ductal carcinoma in situ by gene expression profiling.
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
25
Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation.
Sarah E Pinder. Mod Pathol 2010
Sarah E Pinder. Mod Pathol 2010
12
The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Sarah E Pinder, Ian O Ellis. Breast Cancer Res 2003
Sarah E Pinder, Ian O Ellis. Breast Cancer Res 2003
12
Molecular alterations in columnar cell lesions of the breast.
David J Dabbs, Gloria Carter, Mary Fudge, Yan Peng, Pat Swalsky, Sidney Finkelstein. Mod Pathol 2006
David J Dabbs, Gloria Carter, Mary Fudge, Yan Peng, Pat Swalsky, Sidney Finkelstein. Mod Pathol 2006
12
Mammary ductal carcinoma in situ: a fresh look at architectural patterns.
Gabriel Scripcaru, Ibrahim M Zardawi. Int J Surg Oncol 2012
Gabriel Scripcaru, Ibrahim M Zardawi. Int J Surg Oncol 2012
33
[Consultation in breast surgical pathology: interobserver diagnostic variability of atypical intraductal proliferative lesions].
Amanda Arantes Perez, Débora Balabram, Marcio de Almeida Salles, Helenice Gobbi. Rev Bras Ginecol Obstet 2013
Amanda Arantes Perez, Débora Balabram, Marcio de Almeida Salles, Helenice Gobbi. Rev Bras Ginecol Obstet 2013
20
Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study.
Elena Provenzano, John L Hopper, Graham G Giles, Georgina Marr, Deon J Venter, Jane E Armes. Pathology 2004
Elena Provenzano, John L Hopper, Graham G Giles, Georgina Marr, Deon J Venter, Jane E Armes. Pathology 2004
12
Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.
A Ringberg, I Idvall, M Fernö, H Anderson, L Anagnostaki, P Boiesen, L Bondesson, E Holm, S Johansson, K Lindholm,[...]. Eur J Surg Oncol 2000
A Ringberg, I Idvall, M Fernö, H Anderson, L Anagnostaki, P Boiesen, L Bondesson, E Holm, S Johansson, K Lindholm,[...]. Eur J Surg Oncol 2000
12
12
Ductal carcinoma in situ: what the pathologist needs to know and why.
Anita Bane. Int J Breast Cancer 2013
Anita Bane. Int J Breast Cancer 2013
12
Usefulness and limitations of E-cadherin and β-catenin in the classification of breast carcinomas in situ with mixed pattern.
Douglas S Gomes, Simone S Porto, Rafael M Rocha, Helenice Gobbi. Diagn Pathol 2013
Douglas S Gomes, Simone S Porto, Rafael M Rocha, Helenice Gobbi. Diagn Pathol 2013
14
Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy.
N S Goldstein, L Kestin, F Vicini. Am J Surg Pathol 2000
N S Goldstein, L Kestin, F Vicini. Am J Surg Pathol 2000
12
Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
Douglas S Gomes, Simone S Porto, Débora Balabram, Helenice Gobbi. Diagn Pathol 2014
Douglas S Gomes, Simone S Porto, Débora Balabram, Helenice Gobbi. Diagn Pathol 2014
12
[Importance of a second opinion in breast surgical pathology and therapeutic implications].
Márcio de Almeida Salles, Fernanda Squarcio Fernandes Sanches, Amanda Arantes Perez, Helenice Gobbi. Rev Bras Ginecol Obstet 2008
Márcio de Almeida Salles, Fernanda Squarcio Fernandes Sanches, Amanda Arantes Perez, Helenice Gobbi. Rev Bras Ginecol Obstet 2008
12
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler,[...]. Clin Cancer Res 2004
Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler,[...]. Clin Cancer Res 2004
12
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
12
The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue.
Cornelia Leo, Stefanie Faber, Bettina Hentschel, Michael Höckel, Lars-Christian Horn. Ann Diagn Pathol 2006
Cornelia Leo, Stefanie Faber, Bettina Hentschel, Michael Höckel, Lars-Christian Horn. Ann Diagn Pathol 2006
12
Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009.
Rebecca H Johnson, Franklin L Chien, Archie Bleyer. JAMA 2013
Rebecca H Johnson, Franklin L Chien, Archie Bleyer. JAMA 2013
12
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.
E C Inwald, M Klinkhammer-Schalke, F Hofstädter, F Zeman, M Koller, M Gerstenhauer, O Ortmann. Breast Cancer Res Treat 2013
E C Inwald, M Klinkhammer-Schalke, F Hofstädter, F Zeman, M Koller, M Gerstenhauer, O Ortmann. Breast Cancer Res Treat 2013
12
Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment.
Agnieszka K Witkiewicz, Dayana B Rivadeneira, Adam Ertel, Jessica Kline, Terry Hyslop, Gordon F Schwartz, Paolo Fortina, Erik S Knudsen. Am J Pathol 2011
Agnieszka K Witkiewicz, Dayana B Rivadeneira, Adam Ertel, Jessica Kline, Terry Hyslop, Gordon F Schwartz, Paolo Fortina, Erik S Knudsen. Am J Pathol 2011
12
Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.